Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Study |
| |
| Authors: | Nattachai Srisawat Loredo Lawsin Shigehiko Uchino Rinaldo Bellomo John A Kellum the BEST Kidney Investigators |
| |
| Institution: | (1) The CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illness) Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, 3550 Terrace Street, 15261 Pittsburgh, PA, USA;(2) Halifax Health Medical Center, 303 N. Clyde Morris Blvd, 32114 Daytona Beach, FL, USA;(3) Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, 105-8461 Minato-ku, Tokyo, Japan;(4) Department of Intensive Care and Department of Medicine, Austin Hospital and University of Melbourne, Studley Road, 3084 Heidelberg, Melbourne, Australia |
| |
| Abstract: | Introduction Severe acute kidney injury (AKI) can be treated with either continuous renal replacement therapy (CRRT) or intermittent renal
replacement therapy (IRRT). Limited evidence from existing studies does not support an outcome advantage of one modality versus
the other, and most centers around the word use both modalities according to patient needs. However, cost estimates involve
multiple factors that may not be generalizable to other sites, and, to date, only single-center cost studies have been performed.
The aim of this study was to estimate the cost difference between CRRT and IRRT in the intensive care unit (ICU). |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
